Drugs / epsi-gam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02559258 | Aug 2015 → May 2016 | allergic disease | Tunitas Therapeutics, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | epsi-gam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02559258 ↗ |
| Route | Intravenous | “administered as a single intravenous infusion on Day 1, infused over 30 minutes” NCT02559258 ↗ |